Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome.
暂无分享,去创建一个
[1] B. Williams,et al. Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome. , 1988, The Journal of clinical investigation.
[2] R. Ulevitch,et al. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. , 1988, The Journal of clinical investigation.
[3] B. Beutler,et al. CACHECTIN: MORE THAN A TUMOR NECROSIS FACTOR , 1988 .
[4] R. Strunk,et al. Synergism between gamma interferon and lipopolysaccharide for synthesis of factor B, but not C2, in human fibroblasts , 1988, The Journal of experimental medicine.
[5] B. Beutler,et al. The role of cachectin/TNF in endotoxic shock and cachexia. , 1988, Immunology today.
[6] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[7] W. R. Mccabe,et al. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. , 1987, The American journal of medicine.
[8] B. Beutler,et al. Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype , 1986, The Journal of experimental medicine.
[9] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[10] G. Weissmann,et al. Tumor necrosis factor provokes superoxide anion generation from neutrophils. , 1986, Biochemical and biophysical research communications.
[11] J. Gamble,et al. Stimulation of neutrophils by tumor necrosis factor. , 1986, Journal of immunology.
[12] B. Williams,et al. Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy. , 1986, The Journal of clinical investigation.
[13] J. Tavernier,et al. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. , 1986, Journal of immunology.
[14] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[15] G. Wong,et al. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons , 1986, Nature.
[16] K. Akagawa,et al. Lack of binding of bacterial lipopolysaccharide to mouse lung macrophages and restoration of binding by gamma interferon , 1985, The Journal of experimental medicine.
[17] B. Williams,et al. Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome. , 1985, The Journal of infectious diseases.
[18] K. Shannon,et al. Acquired immune deficiency syndrome in childhood. , 1985, The Journal of pediatrics.
[19] G. Soma,et al. Purification of rabbit tumor necrosis factor , 1985, FEBS letters.
[20] S. Read,et al. Persistent elevation of 2-5A synthetase and prognosis in the AIDS-related complex (ARC). , 1985, Progress in clinical and biological research.
[21] N. H. Ruddle. Lymphotoxin redux. , 1985, Immunology today.
[22] B. Rouse,et al. Regulation of interleukin 1 production by alpha and beta interferons: evidence for both direct and indirect enhancement. , 1985, Journal of interferon research.
[23] B. Aggarwal,et al. Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin , 1984, The Journal of experimental medicine.
[24] J. Goedert,et al. Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. , 1983, The New England journal of medicine.
[25] L. Old,et al. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Bellanti,et al. In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing. , 1983, Journal of immunology.
[27] J. Goedert,et al. Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. , 1982, The Journal of infectious diseases.
[28] S. Russell,et al. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. , 1981, Journal of immunology.
[29] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[30] G. Granger,et al. Lymphocyte in vitro Cytotoxicity: Lymphotoxins of Several Mammalian Species , 1968, Nature.